123 related articles for article (PubMed ID: 8164891)
1. Cerebrovascular responses to soman: time and dose dependent effects.
Goldman H; Berman RF; Hazlett J; Murphy S
Neurotoxicology; 1993; 14(4):469-83. PubMed ID: 8164891
[TBL] [Abstract][Full Text] [Related]
2. Anatomical localization and time course of Fos expression following soman-induced seizures.
Zimmer LA; Ennis M; el-Etri M; Shipley MT
J Comp Neurol; 1997 Feb; 378(4):468-81. PubMed ID: 9034904
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular responses to pentylenetetrazol: time and dose dependent effects.
Goldman H; Berman RF; Hazlett J; Murphy S
Epilepsy Res; 1992 Sep; 12(3):227-42. PubMed ID: 1396548
[TBL] [Abstract][Full Text] [Related]
4. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
[TBL] [Abstract][Full Text] [Related]
5. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats.
Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP
J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to pentylentetrazol-induced convulsions and protection of cerebrovascular integrity by chronic nicotine.
Uzüm G; Bahçekapili N; Diler AS; Ziylan YZ
Int J Neurosci; 2004 Jun; 114(6):735-48. PubMed ID: 15204062
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats.
Clement JG; Broxup B
Neurotoxicology; 1993; 14(4):485-504. PubMed ID: 8164892
[TBL] [Abstract][Full Text] [Related]
8. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
Raveh L; Chapman S; Cohen G; Alkalay D; Gilat E; Rabinovitz I; Weissman BA
Neurotoxicology; 1999 Aug; 20(4):551-9. PubMed ID: 10499354
[TBL] [Abstract][Full Text] [Related]
9. Duration and intensity of behavioral change after sublethal exposure to soman in rats.
Haggerty GC; Kurtz PJ; Armstrong RD
Neurobehav Toxicol Teratol; 1986; 8(6):695-702. PubMed ID: 3808185
[TBL] [Abstract][Full Text] [Related]
10. Behavioral, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman.
Russell RW; Booth RA; Lauretz SD; Smith CA; Jenden DJ
Neurobehav Toxicol Teratol; 1986; 8(6):675-85. PubMed ID: 3808183
[TBL] [Abstract][Full Text] [Related]
11. Seizure-related opening of the blood-brain barrier produced by the anticholinesterase compound, soman: new ultrastructural observations.
Grange-Messent V; Bouchaud C; Jamme M; Lallement G; Foquin A; Carpentier P
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):1-14. PubMed ID: 10099835
[TBL] [Abstract][Full Text] [Related]
12. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats.
Carpentier P; Delamanche IS; Le Bert M; Blanchet G; Bouchaud C
Neurotoxicology; 1990; 11(3):493-508. PubMed ID: 2284054
[TBL] [Abstract][Full Text] [Related]
13. Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism.
Scremin OU; Shih TM; Huynh L; Roch M; Sun W; Chialvo DR; Jenden DJ
Pharmacol Biochem Behav; 2005 Apr; 80(4):529-40. PubMed ID: 15820522
[TBL] [Abstract][Full Text] [Related]
14. Soman-induced depression of brain activity in TAB-pretreated rats: 2-deoxyglucose study.
Pazdernik TL; Cross R; Nelson S; Samson F; McDonough J
Neurotoxicology; 1983; 4(4):27-34. PubMed ID: 6686872
[TBL] [Abstract][Full Text] [Related]
15. Effect of an anticholinesterase compound on the ultrastructure and function of the rat blood-brain barrier: a review and experiment.
Petrali JP; Maxwell DM; Lenz DE; Mills KR
J Submicrosc Cytol Pathol; 1991 Apr; 23(2):331-8. PubMed ID: 2070359
[TBL] [Abstract][Full Text] [Related]
16. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment.
McDonough JH; Dochterman LW; Smith CD; Shih TM
Neurotoxicology; 1995; 16(1):123-32. PubMed ID: 7603632
[TBL] [Abstract][Full Text] [Related]
17. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman.
McDonough JH; Clark TR; Slone TW; Zoeffel D; Brown K; Kim S; Smith CD
Neurotoxicology; 1998 Jun; 19(3):381-91. PubMed ID: 9621344
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
19. Brain regional glucose use during Soman-induced seizures.
McDonough JH; Hackley BE; Cross R; Samson F; Nelson S
Neurotoxicology; 1983; 4(2):203-10. PubMed ID: 6685261
[TBL] [Abstract][Full Text] [Related]
20. Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neurodegenerative events.
Pernot F; Carpentier P; Baille V; Testylier G; Beaup C; Foquin A; Filliat P; Liscia P; Coutan M; Piérard C; Béracochea D; Dorandeu F
Neuroscience; 2009 Sep; 162(4):1351-65. PubMed ID: 19490932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
